Likewise, Shih and colleagues [67] found that miR-214 targeted HDGF in HCC, so miR-214 confers drug resistance in lung cancers but could theoretically target HDGF to hinder tumourigenesis. The gene discussed is HDGF; the disease is lung cancer.